ArticleScientific reports2026
Hypoxia and aspirin additively increase intracellular glutamine accumulation in PIK3CA-mutated colorectal cancer cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
Aspirin exhibits potential as a repurposed agent for preventing and treating cancer, specifically PIK3CA-mutated (MT) colorectal cancer. However, the fundamental biological reasons for the particular antitumor activity of aspirin against PIK3CA-MT colorectal cancer are not yet fully elucidated. We have previously established that aspirin relates to glutamine metabolism in PIK3CA-MT colorectal cancer. In evaluating the antitumor effects of aspirin, it is essential to consider the tumor growth environment, such as hypoxia. The impact of the tumor microenvironment on aspirin efficacy remains unknown. Therefore, we aimed to investigate the mechanisms through which hypoxia influences aspirin- associated intracellular glutamine accumulation in PIK3CA-MT colorectal cancer cell lines. Connectivity Map analysis was used to explore the associations of aspirin with biological pathways in HT-29 (PIK3CA-MT) cells. RNA sequencing was performed on PIK3CA-wild type (WT)/mutant isogenic SW48 cell lines to assess aspirin’s effects under hypoxic conditions. Targeted metabolomics was employed to measure intracellular glutamine levels in PIK3CA-MT HCT116 cells following aspirin treatment and hypoxic stimulation. Bioinformatic analysis revealed associations of aspirin with amino acid metabolism and hypoxic pathways. Under hypoxic conditions, aspirin enhanced amino acid uptake in PIK3CA-MT cells. Targeted metabolomics showed that aspirin treatment and hypoxic stimulation additively upregulated intracellular glutamine levels in PIK3CA-MT cells. This increase was reversed by V-9302, an inhibitor of the glutamine transporter ASCT2, which demonstrated antitumor potential in combination with aspirin. Our findings suggest that the combination of aspirin and hypoxia significantly enhances intracellular glutamine accumulation in PIK3CA-MT colorectal cancer under hypoxic conditions, emphasizing glutamine metabolism as a potential therapeutic target to enhance aspirin’s efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.